数字技术辅助关节镜精准化、个性化治疗前交叉韧带损伤

注册号:

Registration number:

ChiCTR2000037284 

最近更新日期:

Date of Last Refreshed on:

2020-10-12 00:29:28 

注册时间:

Date of Registration:

2020-08-27 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

数字技术辅助关节镜精准化、个性化治疗前交叉韧带损伤

Public title:

Digital technology-assisted arthroscopy for precise and personalized treatment of anterior cruciate ligament injury: a randomized controlled trial.

注册题目简写:

English Acronym:

研究课题的正式科学名称:

数字技术辅助关节镜精准化、个性化治疗前交叉韧带损伤

Scientific title:

Digital technology-assisted arthroscopy for precise and personalized treatment of anterior cruciate ligament injury

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

桂定坤 

研究负责人:

袁锋 

Applicant:

Gui Dingkun 

Study leader:

Yuan Feng 

申请注册联系人电话:

Applicant telephone:

+86 21 38297241

研究负责人电话:

Study leader's
telephone:

+86 13917819693

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

sldykjc@163.com

研究负责人电子邮件:

Study leader's E-mail:

yuanfeng@188.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市浦东新区环湖西三路222号

研究负责人通讯地址:

上海市浦东新区环湖西三路222号

Applicant address:

222 Third Huanhu Road West, Pudong New Area, Shanghai

Study leader's address:

222 Third Huanhu Road West, Pudong New Area, Shanghai

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

上海市第六人民医院东院

Applicant's institution:

East Hospital of Shanghai Sixth People's Hospital

研究负责人所在单位:

上海市第六人民医院东院

Affiliation of the Leader:

East Hospital of Shanghai Sixth People's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2020-070

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市第六人民医院东院伦理委员会

Name of the ethic committee:

Ethics Committee of Eastern Hospital of Shanghai Sixth People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2020-08-27 00:00:00

伦理委员会联系人:

王建波

Contact Name of the ethic committee:

Wang Jianbo

伦理委员会联系地址:

上海市浦东新区环湖西三路222号

Contact Address of the ethic committee:

222 Third Huanhu Road West, Pudong New Area, Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海市第六人民医院东院

Primary sponsor:

East Hospital of Shanghai Sixth People's Hospital

研究实施负责(组长)单位地址:

上海市浦东新区环湖西三路222号

Primary sponsor's address:

222 Third Huanhu Road West, Pudong New Area, Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市第六人民医院东院

具体地址:

浦东新区环湖西三路222号

Institution
hospital:

East Hospital of Shanghai Sixth People's Hospital

Address:

222 Third Huanhu Road West, Pudong New Area

经费或物资来源:

上海市申康医院发展集团

Source(s) of funding:

Shanghai Shenkang Hospital development group

研究疾病:

前交叉韧带损伤  

Target disease:

ACL injury

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

通过纳入160名符合条件的ACL损伤患者,进行随机病例对照试验,从不同维度不同角度验证数字技术辅助关节镜ACL双束八股解剖重建相较于传统方案的优势,促进ACL双束八股解剖重建手术方案的精准化和个性化推广。  

Objectives of Study:

A randomized case-control trial was conducted in 160 eligible patients with ACL injury. The advantages of digital assisted arthroscopic ACL double bundle eight strand anatomical reconstruction compared with the traditional method were verified from different dimensions and different angles, so as to promote the precision and personalized promotion of the surgical scheme of double bundle eight strand ACL anatomical reconstruction.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1) 既往膝关节手术史,明显膝关节退行性变患者;
2) 有重大免疫缺陷史或对麻醉药物过敏者;
3) 对手术治疗明显排斥的患者;
4) 肿瘤患者;
5) 患有出血性疾病者;
6) 患有结核、肝炎等传染性疾病患者及肝肾功能不全的患者;
7) 精神病患者;
所有患者凡符合上述任意一项者,视为不适宜纳入本项试验研究。

Exclusion criteria:

1) Patients with previous knee joint operation history and obvious knee joint degeneration;
2) Patients with a history of major immunodeficiency or allergy to narcotic drugs;
3) For patients who were obviously rejected by surgery;
4) Cancer patients;
5) Patients with hemorrhagic diseases;
6) Patients with tuberculosis, hepatitis and other infectious diseases and patients with liver and kidney dysfunction; 7) Mental patients;
All patients who met any of the above criteria were considered not suitable for inclusion in this study.

研究实施时间:

Study execute time:

From 2020-10-01 00:00:00 To 2022-09-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-10-01 00:00:00 To 2021-09-30 00:00:00

干预措施:

Interventions:

组别:

数字辅助组

样本量:

80

Group:

Digital assistant group

Sample size:

干预措施:

术前方案制定时应用数字技术辅助制定方案并术前模拟操作

干预措施代码:

Intervention:

Digital technology was used to assist in the formulation of preoperative plan and the operation was simulated before operation

Intervention code:

组别:

传统方案组

样本量:

80

Group:

Traditional solutions group

Sample size:

干预措施:

依据传统方案进行术前准备,阅读MRI后,制定手术计划

干预措施代码:

Intervention:

Preoperative preparation was carried out according to the traditional plan, and the operation plan was made after reading MRI

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市第六人民医院东院 

单位级别:

三级甲等 

Institution
hospital:

East Hospital of Shanghai Sixth People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

膝关节活动度

指标类型:

主要指标

Outcome:

Knee range of motion

Type:

Primary indicator

测量时间点:

术前、术后即刻、术后12周、术后6月、术后1年。

测量方法:

Measure time point of outcome:

Before operation, immediately after operation, 12 weeks after operation, 6 months after operation and 1 year after operation.

Measure method:

指标中文名:

VAS评分

指标类型:

主要指标

Outcome:

VAS degree

Type:

Primary indicator

测量时间点:

术前、术后即刻、术后12周、术后6月、术后1年。

测量方法:

Measure time point of outcome:

Before operation, immediately after operation, 12 weeks after operation, 6 months after operation and 1 year after operation.

Measure method:

指标中文名:

KSS评分

指标类型:

主要指标

Outcome:

KSS degree

Type:

Primary indicator

测量时间点:

术前、术后即刻、术后12周、术后6月、术后1年。

测量方法:

Measure time point of outcome:

Before operation, immediately after operation, 12 weeks after operation, 6 months after operation and 1 year after operation.

Measure method:

指标中文名:

骨隧道改变

指标类型:

主要指标

Outcome:

Bone tunnel changes

Type:

Primary indicator

测量时间点:

术前、术后即刻、术后12周、术后6月、术后1年。

测量方法:

CT、MRI

Measure time point of outcome:

Before operation, immediately after operation, 12 weeks after operation, 6 months after operation and 1 year after operation.

Measure method:

CT, MRI

指标中文名:

术者满意度

指标类型:

主要指标

Outcome:

Operator satisfaction

Type:

Primary indicator

测量时间点:

术后即刻

测量方法:

Measure time point of outcome:

immediately after operation

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 40 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

随机数法

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

单盲

Blinding:

Single blind

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

第六人民医院东院官网公布www.6thhosp-east.com

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

www.6thhosp-east.com

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF:Excel系统 EDC:Winning 临床数据管理系统(可导入EXCEL数据)

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF: Excel system EDC: Winning clinical data management system (Excel data can be imported)

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-08-27 23:31:15